LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) Stock Analyst Earnings Estimates
NASDAQ:LIXT - Nasdaq - US5393193017 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 200K | N/A -100.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| EBITDA YoY % growth | -2.4M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.4M | -2.65M -10.42% | N/A 19.62% | N/A 15.02% | N/A -18.23% | N/A -16.36% | N/A -31.33% | N/A -105.50% | N/A 6.10% | N/A 19.33% | |
| Operating Margin | N/A | -1,325.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |